BiomeSense Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$1.7M
- Investors
-
20
BiomeSense General Information
Description
Developer of an integrated biosensor and bioinformatics platform designed to transform microbiome data generation and analysis. The company's proprietary technology produces and analyzes accurate, large-scale, and densely longitudinal microbiome datasets to discover, validate, and commercialize novel microbiome biomarkers at scale, enabling doctors with a high-resolution microbiome database, an unprecedented resource that the company will use to develop the next generation of novel microbiome-based biomarkers, therapeutics, and consumer products.
Contact Information
Website
www.biomesense.comCorporate Office
- 2242 West Harrison Street
- Suite 201
- Chicago, IL 60612
- United States
Corporate Office
- 2242 West Harrison Street
- Suite 201
- Chicago, IL 60612
- United States
BiomeSense Timeline
BiomeSense Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Grant | 04-Mar-2025 | $1.7M | Completed | Startup | ||
| 9. Grant | 06-Mar-2024 | Completed | Generating Revenue | |||
| 8. Seed Round | 19-Dec-2023 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 01-Jul-2021 | Completed | Generating Revenue | |||
| 6. Grant | 30-Jun-2021 | Completed | Generating Revenue | |||
| 5. Seed Round | 02-Oct-2019 | Completed | Startup | |||
| 4. Accelerator/Incubator | 20-Feb-2019 | Completed | Startup | |||
| 3. Accelerator/Incubator | 06-Jun-2018 | Completed | Startup | |||
| 2. Grant | Completed | Startup | ||||
| 1. University Spin-Out | 01-Jan-2018 | Completed | Startup |
BiomeSense Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-4 | ||||||||
| Seed-3 | ||||||||
| Seed-2 | 398,724 | $0.000100 | $1.25 | $1.25 | 1x | $1.25 | 7.36% | |
| Seed-1 | 697,763 | $0.000100 | $2.87 | $2.87 | 1x | $2.87 | 12.87% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
BiomeSense Comparisons
Industry
Financing
Details
BiomeSense Competitors (5)
One of BiomeSense’s 5 competitors is Intus Biosciences, a Venture Capital-Backed company based in Farmington, CT.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Intus Biosciences | Venture Capital-Backed | Farmington, CT | ||||
| Biosortia Microbiomics | Venture Capital-Backed | Dublin, OH | ||||
| Menarini Silicon Biosystems | Formerly VC-backed | Castel Maggiore, Italy | ||||
| Diversigen | Formerly VC-backed | New Brighton, MN | ||||
| CosmosID | Formerly VC-backed | Germantown, MD |
BiomeSense Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
BiomeSense Patents
BiomeSense Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4264283-A1 | Systems and methods for processing stool samples | Pending | 15-Dec-2020 | ||
| US-20240110854-A1 | Systems and methods for processing stool samples | Pending | 15-Dec-2020 | ||
| EP-4264283-A4 | Systems and methods for processing stool samples | Pending | 15-Dec-2020 | ||
| US-20220167950-A1 | Systems and methods for processing stool samples | Pending | 20-Jun-2019 | ||
| US-20200397415-A1 | Systems and methods for stool sample collection | Inactive | 20-Jun-2019 | A61B10/0038 |
BiomeSense Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
BiomeSense Investors (20)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bluestein Ventures | Venture Capital | Minority | ||
| Chicago Early Growth Ventures | Venture Capital | Minority | ||
| Emil Capital Partners | Venture Capital | Minority | ||
| Harvest Ridge Capital | Venture Capital | Minority | ||
| IrishAngels | Angel Group | Minority |
BiomeSense FAQs
-
When was BiomeSense founded?
BiomeSense was founded in 2018.
-
Where is BiomeSense headquartered?
BiomeSense is headquartered in Chicago, IL.
-
What is the size of BiomeSense?
BiomeSense has 9 total employees.
-
What industry is BiomeSense in?
BiomeSense’s primary industry is Discovery Tools (Healthcare).
-
Is BiomeSense a private or public company?
BiomeSense is a Private company.
-
What is BiomeSense’s current revenue?
The current revenue for BiomeSense is .
-
How much funding has BiomeSense raised over time?
BiomeSense has raised $9.1M.
-
Who are BiomeSense’s investors?
Bluestein Ventures, Chicago Early Growth Ventures, Emil Capital Partners, Harvest Ridge Capital, and IrishAngels are 5 of 20 investors who have invested in BiomeSense.
-
Who are BiomeSense’s competitors?
Intus Biosciences, Biosortia Microbiomics, Menarini Silicon Biosystems, Diversigen, and CosmosID are competitors of BiomeSense.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
